检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Patient-reported outcomes (PROS) from patients with RET-mutant medullary thyroid cancer (MTC) and ret fusion-positive TC treated with pralsetinib in the arrow trial

Julien Hadoux, Hu Mimi I, Brose Marcia S.,Elena Garralda, Christine Spitzweg,Noemi Reguart, Cao Christine Do,Forster Martin D.,Teresa Alonso-Gordoa,Teresa Barata, Astrid Scalori,Alena Zalutskaya, Peter Trask,Vivek Subbiah

Endocrine Abstracts（2022）

引用 0|浏览0
暂无评分
摘要
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
更多
查看译文
关键词
thyroid,arrow trial,patient-reported,ret-mutant,fusion-positive
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要